ID

21426

Descrizione

Study of Forodesine Hydrochloride in Patients With Advanced, Fludarabine-refractory Chronic Lymphocytic Leukemia (CLL); ODM derived from: https://clinicaltrials.gov/show/NCT00289549

collegamento

https://clinicaltrials.gov/show/NCT00289549

Keywords

versioni (1)
  1. 21/04/17 21/04/17 -
Caricato su

21 aprile 2017

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Leukemia, Lymphocytic, Chronic NCT00289549

Inglese

Eligibility Leukemia, Lymphocytic, Chronic NCT00289549

1 moduli  
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
ages 18 years and older
Descrizione

Age

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0001779
diagnosis of cll established by peripheral blood and bone marrow examination and using the standard criteria
Descrizione

Chronic Lymphocytic Leukemia | Blood--Examination Peripheral | Bone Marrow Examination | Criteria Standard

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0023434
UMLS CUI [2,1]
C3826648
UMLS CUI [2,2]
C0205100
UMLS CUI [3]
C0005957
UMLS CUI [4,1]
C0243161
UMLS CUI [4,2]
C1442989
patients with rai stage iii or iv, or earlier stage with massive, symptomatic lymphadenopathy requiring therapy
Descrizione

Rai Staging System | Lymphadenopathy massive Symptomatic | Therapeutic procedure Patient need for

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1514715
UMLS CUI [2,1]
C0235599
UMLS CUI [2,2]
C0231220
UMLS CUI [3,1]
C0087111
UMLS CUI [3,2]
C0686904
primary resistance to fludarabine-based therapy (no complete response [cr] or partial response [pr]) or progressive disease within 6 months of response to prior fludarabine containing regimen.
Descrizione

Therapeutic procedure Fludarabine Based | Resistance Primary | Complete response Absent | Partial response Absent | Progressive Disease

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0059985
UMLS CUI [1,3]
C1705938
UMLS CUI [2,1]
C1514892
UMLS CUI [2,2]
C0205225
UMLS CUI [3,1]
C0677874
UMLS CUI [3,2]
C0332197
UMLS CUI [4,1]
C1521726
UMLS CUI [4,2]
C0332197
UMLS CUI [5]
C1335499
ecog performance status of 0, 1, 2 or 3
Descrizione

ECOG performance status

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1520224
willing to take adequate contraception (i.e. latex condom, cervical cap, diaphragm, abstinence, etc.) for the entire duration of the study and 3 months after
Descrizione

Contraceptive methods | Latex condom | CERVICAL CAP FOR CONTRACEPTIVE USE | Vaginal contraceptive diaphragm | Sexual Abstinence

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0700589
UMLS CUI [2]
C3873750
UMLS CUI [3]
C0493327
UMLS CUI [4]
C0042241
UMLS CUI [5]
C0036899
all investigational treatments should have been discontinued for at least 1 week prior to the initiation of the study drug.
Descrizione

Investigational Therapies Discontinued

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0949266
UMLS CUI [1,2]
C1444662
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
pregnant or nursing
Descrizione

Pregnancy | Breast Feeding

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
unable or unwilling to sign consent
Descrizione

Informed Consent Unable | Informed Consent Unwilling

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C1299582
UMLS CUI [2,1]
C0021430
UMLS CUI [2,2]
C0558080
severe, ongoing co-morbid conditions, which would preclude safe delivery of the investigational therapy
Descrizione

Comorbidity Severe | Investigational Therapy Excluded

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0205082
UMLS CUI [2,1]
C0949266
UMLS CUI [2,2]
C2828389
active serious infections that are not controlled by antibiotics
Descrizione

Communicable Diseases Serious Uncontrolled | Antibiotics

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0009450
UMLS CUI [1,2]
C0205404
UMLS CUI [1,3]
C0205318
UMLS CUI [2]
C0003232
ecog performance status 4
Descrizione

ECOG performance status

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1520224
inadequate renal function: creatinine 2.0 or more unless related to the disease
Descrizione

Abnormal renal function | Creatinine measurement, serum | Serum creatinine measurement Disease Related

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0151746
UMLS CUI [2]
C0201976
UMLS CUI [3,1]
C0201976
UMLS CUI [3,2]
C0012634
UMLS CUI [3,3]
C0439849
inadequate liver function: bilirubin 3.0 or more, transaminases 3 x upper limit of normal or more unless related to the disease
Descrizione

Liver function abnormal | Serum total bilirubin measurement | Transaminases increased | Transaminases increased Disease Related

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0151766
UMLS CUI [2]
C1278039
UMLS CUI [3]
C0438717
UMLS CUI [4,1]
C0438717
UMLS CUI [4,2]
C0012634
UMLS CUI [4,3]
C0439849
known positive test for hiv
Descrizione

HIV Seropositivity

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0019699
patients with known hepatitis b and/or hepatitis c active infection
Descrizione

Hepatitis B | Hepatitis C

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0019163
UMLS CUI [2]
C0019196
Ritorna all'inizio della pagina

Similar models

Eligibility Leukemia, Lymphocytic, Chronic NCT00289549

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
ages 18 years and older
boolean
C0001779 (UMLS CUI [1])
Chronic Lymphocytic Leukemia | Blood--Examination Peripheral | Bone Marrow Examination | Criteria Standard
Item
diagnosis of cll established by peripheral blood and bone marrow examination and using the standard criteria
boolean
C0023434 (UMLS CUI [1])
C3826648 (UMLS CUI [2,1])
C0205100 (UMLS CUI [2,2])
C0005957 (UMLS CUI [3])
C0243161 (UMLS CUI [4,1])
C1442989 (UMLS CUI [4,2])
Rai Staging System | Lymphadenopathy massive Symptomatic | Therapeutic procedure Patient need for
Item
patients with rai stage iii or iv, or earlier stage with massive, symptomatic lymphadenopathy requiring therapy
boolean
C1514715 (UMLS CUI [1])
C0235599 (UMLS CUI [2,1])
C0231220 (UMLS CUI [2,2])
C0087111 (UMLS CUI [3,1])
C0686904 (UMLS CUI [3,2])
Therapeutic procedure Fludarabine Based | Resistance Primary | Complete response Absent | Partial response Absent | Progressive Disease
Item
primary resistance to fludarabine-based therapy (no complete response [cr] or partial response [pr]) or progressive disease within 6 months of response to prior fludarabine containing regimen.
boolean
C0087111 (UMLS CUI [1,1])
C0059985 (UMLS CUI [1,2])
C1705938 (UMLS CUI [1,3])
C1514892 (UMLS CUI [2,1])
C0205225 (UMLS CUI [2,2])
C0677874 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
C1521726 (UMLS CUI [4,1])
C0332197 (UMLS CUI [4,2])
C1335499 (UMLS CUI [5])
ECOG performance status
Item
ecog performance status of 0, 1, 2 or 3
boolean
C1520224 (UMLS CUI [1])
Contraceptive methods | Latex condom | CERVICAL CAP FOR CONTRACEPTIVE USE | Vaginal contraceptive diaphragm | Sexual Abstinence
Item
willing to take adequate contraception (i.e. latex condom, cervical cap, diaphragm, abstinence, etc.) for the entire duration of the study and 3 months after
boolean
C0700589 (UMLS CUI [1])
C3873750 (UMLS CUI [2])
C0493327 (UMLS CUI [3])
C0042241 (UMLS CUI [4])
C0036899 (UMLS CUI [5])
Investigational Therapies Discontinued
Item
all investigational treatments should have been discontinued for at least 1 week prior to the initiation of the study drug.
boolean
C0949266 (UMLS CUI [1,1])
C1444662 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Pregnancy | Breast Feeding
Item
pregnant or nursing
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Informed Consent Unable | Informed Consent Unwilling
Item
unable or unwilling to sign consent
boolean
C0021430 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])
C0021430 (UMLS CUI [2,1])
C0558080 (UMLS CUI [2,2])
Comorbidity Severe | Investigational Therapy Excluded
Item
severe, ongoing co-morbid conditions, which would preclude safe delivery of the investigational therapy
boolean
C0009488 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0949266 (UMLS CUI [2,1])
C2828389 (UMLS CUI [2,2])
Communicable Diseases Serious Uncontrolled | Antibiotics
Item
active serious infections that are not controlled by antibiotics
boolean
C0009450 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C0205318 (UMLS CUI [1,3])
C0003232 (UMLS CUI [2])
ECOG performance status
Item
ecog performance status 4
boolean
C1520224 (UMLS CUI [1])
Abnormal renal function | Creatinine measurement, serum | Serum creatinine measurement Disease Related
Item
inadequate renal function: creatinine 2.0 or more unless related to the disease
boolean
C0151746 (UMLS CUI [1])
C0201976 (UMLS CUI [2])
C0201976 (UMLS CUI [3,1])
C0012634 (UMLS CUI [3,2])
C0439849 (UMLS CUI [3,3])
Liver function abnormal | Serum total bilirubin measurement | Transaminases increased | Transaminases increased Disease Related
Item
inadequate liver function: bilirubin 3.0 or more, transaminases 3 x upper limit of normal or more unless related to the disease
boolean
C0151766 (UMLS CUI [1])
C1278039 (UMLS CUI [2])
C0438717 (UMLS CUI [3])
C0438717 (UMLS CUI [4,1])
C0012634 (UMLS CUI [4,2])
C0439849 (UMLS CUI [4,3])
HIV Seropositivity
Item
known positive test for hiv
boolean
C0019699 (UMLS CUI [1])
Hepatitis B | Hepatitis C
Item
patients with known hepatitis b and/or hepatitis c active infection
boolean
C0019163 (UMLS CUI [1])
C0019196 (UMLS CUI [2])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial